HomeInsightsStock Comparison

Ambalal Sarabhai Enterprises Ltd vs Gufic Biosciences Ltd Stock Comparison

Ambalal Sarabhai Enterprises Ltd vs Gufic Biosciences Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 35.83 as of 22 Jul 12:21.
  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 10.4 on March 2020 to 54.8 on March 2025 . This represents a CAGR of 31.91% over 6 yearsThe P/E Ratio of Gufic BioSciences Ltd changed from 33 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Ambalal Sarabhai Enterprises Ltd changed from ₹ 145.99 crore on March 2020 to ₹ 268.6 crore on March 2025 . This represents a CAGR of 10.70% over 6 yearsThe Market Cap of Gufic BioSciences Ltd changed from ₹ 2839 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The revenue of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ 66.45 crore as compare to the Dec '24 revenue of ₹ 51.73 crore. This represent the growth of 28.46% The revenue of Gufic BioSciences Ltd for the Mar '25 is ₹ 205.41 crore as compare to the Dec '24 revenue of ₹ 209.66 crore. This represent the decline of -2.03%.
  • The ebitda of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ -0.07 crore as compare to the Dec '24 ebitda of ₹ 5.06 crore. This represent the decline of -101% The ebitda of Gufic BioSciences Ltd for the Mar '25 is ₹ 26.77 crore as compare to the Dec '24 ebitda of ₹ 35.79 crore. This represent the decline of -25.2%.
  • The net profit of Ambalal Sarabhai Enterprises Ltd changed from ₹ -4.87 crore to ₹ -0.27 crore over 8 quarters. This represents a CAGR of -76.45% The net profit of Gufic BioSciences Ltd changed from ₹ 20.62 crore to ₹ 7.72 crore over 8 quarters. This represents a CAGR of -38.81% .
  • The Dividend Payout of Ambalal Sarabhai Enterprises Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.14 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ambalal Sarabhai Enterprises Ltd

  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses.
  • Each subsidiary is a distinct entity contributing its unique expertise and capabilities.
  • It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
  • ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
  • It operates in two segments, pharmaceuticals and electronics.

About Gufic BioSciences Ltd

  • Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
  • Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
  • The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
  • The Company was incorporated in July, 1984.
  • The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

Ambalal Sarabhai Enterprises Ltd News Hub

News

Ambalal Sarabhai Enterprises schedules AGM

Ambalal Sarabhai Enterprises announced that the 47th Annual General Meeting(AGM) of the co...

Read more

07 Jun 2025 09:30

News

Ambalal Sarabhai Enterprises to table results

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

23 May 2025 17:45

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

06 Feb 2025 11:55

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

05 Nov 2024 13:38

News

Ambalal Sarabhai Enterprises announces board meeting date

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

03 Aug 2024 10:31

News

Ambalal Sarabhai Enterprises to conduct AGM

Ambalal Sarabhai Enterprises announced that the 46th Annual General Meeting (AGM) of the c...

Read more

29 May 2024 15:01

Gufic BioSciences Ltd News Hub

News

Gufic BioSciences appoints senior management personnel

Gufic BioSciences has appointed Rajesh Kaul as Senior President ' Sparsh Cluster, Senior M...

Read more

02 Jul 2025 18:34

News

Board of Gufic BioSciences recommends final dividend

Gufic BioSciences announced that the Board of Directors of the Company at its meeting held...

Read more

30 May 2025 20:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

24 May 2025 18:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

08 Feb 2025 14:21

News

Gufic Biosciences tumbles after Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expense...

Read more

18 Nov 2024 11:09

News

Gufic Biosciences Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expense...

Read more

15 Nov 2024 12:29

SWOT Analysis Of Gufic BioSciences Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Ambalal Sarabhai Enterprises Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gufic BioSciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Ambalal Sarabhai Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd

Which company has a larger market capitalization, Ambalal Sarabhai Enterprises Ltd or Gufic BioSciences Ltd?

Market cap of Ambalal Sarabhai Enterprises Ltd is 274 Cr while Market cap of Gufic BioSciences Ltd is 3,835 Cr

What are the key factors driving the stock performance of Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd?

The stock performance of Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd?

As of July 22, 2025, the Ambalal Sarabhai Enterprises Ltd stock price is INR ₹35.86. On the other hand, Gufic BioSciences Ltd stock price is INR ₹382.45.

How do dividend payouts of Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd compare?

To compare the dividend payouts of Ambalal Sarabhai Enterprises Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions